Logo image of ALBOA.PA

BOA CONCEPT SACA (ALBOA.PA) Stock Fundamental Analysis

EPA:ALBOA - Euronext Paris - Matif - FR0011365907 - Common Stock - Currency: EUR

21  0 (0%)

Fundamental Rating

3

ALBOA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. ALBOA has a bad profitability rating. Also its financial health evaluation is rather negative. ALBOA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALBOA had positive earnings in the past year.
In the past year ALBOA has reported a negative cash flow from operations.
ALBOA had positive earnings in 4 of the past 5 years.
In multiple years ALBOA reported negative operating cash flow during the last 5 years.
ALBOA.PA Yearly Net Income VS EBIT VS OCF VS FCFALBOA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 2M -2M -4M -6M -8M

1.2 Ratios

The last Return On Invested Capital (0.12%) for ALBOA is well below the 3 year average (7.06%), which needs to be investigated, but indicates that ALBOA had better years and this may not be a problem.
Industry RankSector Rank
ROA 1.15%
ROE 1.89%
ROIC 0.12%
ROA(3y)6.65%
ROA(5y)6.64%
ROE(3y)10.34%
ROE(5y)11.59%
ROIC(3y)7.06%
ROIC(5y)N/A
ALBOA.PA Yearly ROA, ROE, ROICALBOA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

ALBOA's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of ALBOA has declined.
In the last couple of years the Gross Margin of ALBOA has grown nicely.
Industry RankSector Rank
OM 0.3%
PM (TTM) 2.45%
GM 71.87%
OM growth 3Y-71.55%
OM growth 5YN/A
PM growth 3Y-42.99%
PM growth 5YN/A
GM growth 3Y10.58%
GM growth 5YN/A
ALBOA.PA Yearly Profit, Operating, Gross MarginsALBOA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALBOA is destroying value.
The number of shares outstanding for ALBOA has been reduced compared to 1 year ago.
ALBOA has a worse debt/assets ratio than last year.
ALBOA.PA Yearly Shares OutstandingALBOA.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 200K 400K 600K 800K
ALBOA.PA Yearly Total Debt VS Total AssetsALBOA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

An Altman-Z score of 2.44 indicates that ALBOA is not a great score, but indicates only limited risk for bankruptcy at the moment.
A Debt/Equity ratio of 0.36 indicates that ALBOA is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Altman-Z 2.44
ROIC/WACC0.02
WACC8.03%
ALBOA.PA Yearly LT Debt VS Equity VS FCFALBOA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

ALBOA has a Current Ratio of 3.73. This indicates that ALBOA is financially healthy and has no problem in meeting its short term obligations.
ALBOA has a Quick Ratio of 3.19. This indicates that ALBOA is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 3.73
Quick Ratio 3.19
ALBOA.PA Yearly Current Assets VS Current LiabilitesALBOA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

4

3. Growth

3.1 Past

ALBOA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -79.47%.
ALBOA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -49.40% yearly.
ALBOA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -18.77%.
Measured over the past years, ALBOA shows a decrease in Revenue. The Revenue has been decreasing by -4.24% on average per year.
EPS 1Y (TTM)-79.47%
EPS 3Y-49.4%
EPS 5YN/A
EPS Q2Q%58.06%
Revenue 1Y (TTM)-18.77%
Revenue growth 3Y-4.24%
Revenue growth 5YN/A
Sales Q2Q%25.94%

3.2 Future

The Earnings Per Share is expected to grow by 231.66% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 10.85% on average over the next years. This is quite good.
EPS Next Y834.62%
EPS Next 2Y231.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year17.94%
Revenue Next 2Y10.85%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALBOA.PA Yearly Revenue VS EstimatesALBOA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M 20M 25M
ALBOA.PA Yearly EPS VS EstimatesALBOA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0.5 1 1.5 2 2.5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 63.64, the valuation of ALBOA can be described as expensive.
The average S&P500 Price/Earnings ratio is at 26.32. ALBOA is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 8.39, the valuation of ALBOA can be described as very reasonable.
The average S&P500 Price/Forward Earnings ratio is at 22.19. ALBOA is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 63.64
Fwd PE 8.39
ALBOA.PA Price Earnings VS Forward Price EarningsALBOA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 51.27
ALBOA.PA Per share dataALBOA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

ALBOA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALBOA's earnings are expected to grow with 231.66% in the coming years.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y231.66%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALBOA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BOA CONCEPT SACA

EPA:ALBOA (6/17/2025, 7:00:00 PM)

21

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.26%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap20.37M
Analysts86.67
Price Target25.5 (21.43%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-26.47%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)42.11%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)27.67%
Valuation
Industry RankSector Rank
PE 63.64
Fwd PE 8.39
P/S 1.56
P/FCF N/A
P/OCF N/A
P/B 1.21
P/tB 1.37
EV/EBITDA 51.27
EPS(TTM)0.33
EY1.57%
EPS(NY)2.5
Fwd EY11.92%
FCF(TTM)-9.61
FCFYN/A
OCF(TTM)-0.32
OCFYN/A
SpS13.43
BVpS17.33
TBVpS15.28
PEG (NY)0.08
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.15%
ROE 1.89%
ROCE 0.17%
ROIC 0.12%
ROICexc 0.18%
ROICexgc 0.21%
OM 0.3%
PM (TTM) 2.45%
GM 71.87%
FCFM N/A
ROA(3y)6.65%
ROA(5y)6.64%
ROE(3y)10.34%
ROE(5y)11.59%
ROIC(3y)7.06%
ROIC(5y)N/A
ROICexc(3y)18.28%
ROICexc(5y)N/A
ROICexgc(3y)20.84%
ROICexgc(5y)N/A
ROCE(3y)9.61%
ROCE(5y)N/A
ROICexcg growth 3Y-83.36%
ROICexcg growth 5YN/A
ROICexc growth 3Y-82.81%
ROICexc growth 5YN/A
OM growth 3Y-71.55%
OM growth 5YN/A
PM growth 3Y-42.99%
PM growth 5YN/A
GM growth 3Y10.58%
GM growth 5YN/A
F-Score2
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Debt/EBITDA 15.33
Cap/Depr 2548.21%
Cap/Sales 69.22%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.73
Quick Ratio 3.19
Altman-Z 2.44
F-Score2
WACC8.03%
ROIC/WACC0.02
Cap/Depr(3y)1077.99%
Cap/Depr(5y)678.81%
Cap/Sales(3y)29.49%
Cap/Sales(5y)20.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-79.47%
EPS 3Y-49.4%
EPS 5YN/A
EPS Q2Q%58.06%
EPS Next Y834.62%
EPS Next 2Y231.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.77%
Revenue growth 3Y-4.24%
Revenue growth 5YN/A
Sales Q2Q%25.94%
Revenue Next Year17.94%
Revenue Next 2Y10.85%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-97.64%
EBIT growth 3Y-72.75%
EBIT growth 5YN/A
EBIT Next Year975%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-720.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-140.59%
OCF growth 3YN/A
OCF growth 5YN/A